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A total of 133 women with RA were included in this prospective, randomized, blinded, 16-week controlled study. The patients were separated into three groups as WB (n = 33), LB (n = 33), and control (n = 34). An isokinetic dynamometer was used to evaluate the muscle strength of knees. The same expert rheumatologist evaluated disease activity (DAS-28) and functional status (health assessment questionnaire). Total body densitometry was used to measure body composition. The treatment was applied three times per week, and all groups were assessed at baseline and after 8 and 16 weeks. Additionally, the compliance of patients and concomitant medications was evaluated. A P value less than 0.05 was considered significant. Eighty-two patients completed the study. Before treatment, the three groups were matched for age, body composition, functional status, muscle strength, and concomitant medications. At the end of the treatment, no significant changes in knee muscle strength and body composition were found among the three groups. However, a significant improvement in disease activity and functional capacity was observed in the WB group after 8 and 16 weeks.
Aquatic aerobic exercises seem to be more effective in women with RA.
This report aimed to describe the engineering and validation of a humanized tissue-engineered bone organ (hTEBO) for preclinical research on primary bone tumors. The harvested pelvic bone and marrow fragments were taken from the patients while reaming the acetabulum during hip arthroplasty. HTEBOs were engineered by embedding fragments in a fibrin matrix containing bone morphogenetic protein-7 and implanted into NOD-SCİD mice. One group of hTEBOs was harvested to analyze the degree of humanization after 10 weeks of subcutaneous growth. The second group was injected with human luciferase-labeled OS (Luc-SAOS-2) cells, and tumor growth was followed in vivo with bioluminescence imaging. The OS tumors were harvested and analyzed after 5 weeks and compared with the tumors created via intratibial injection.
A new bone organ containing human bone matrix as well as viable and functional human hematopoietic cells developed after 10 weeks of in vivo growth. Five weeks after injecting Luc-SAOS-2 cells into this humanized bone microenvironment, spontaneous metastatic spread to the lung was evident.
The study reported an in vivo model that contained human bone matrix and marrow components in one organ. This novel platform might enable preclinical research on primary bone tumors to test new treatment options.
